View Amendment Current Amendment: 1 to Bill 3793 The JUDICIARY COMMITTEE proposes the following Amendment No. 1 to H. 3793 (COUNCIL\NBD\12061AC12):

Reference is to the bill as introduced.

Amend the bill, as and if amended, by striking all after the enacting words and inserting:

/SECTION      1.      Section 44-53-190 of the 1976 Code, as last amended by Act 267 of 2002, is further amended to read:

     "Section 44-53-190.      (aA)      The controlled substances listed in this section are included in Schedule I.
     (bB)      Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:
           1.      Acetylmethadol
           2.      Allylprodine
           3.      Alphacetylmethadol
           4.      Alphameprodine
           5.      Alphamethadol
           6.      Benzethidine
           7.      Betacetylmethadol
           8.      Betameprodine
           9.      Betamethadol
           10.      Betaprodine
           11.      Clonitazene
           12.      Dextromoramide
           13.      [Deleted]
           14.      Diampromide
           15.      Diethylthiambutene
           16.      Dimenoxadol
           17.      Dimepheptanol
           18.      Dimethylthiambutene
           19.      Dioxaphetyl butyrate
           20.      Dipipanone
           21.      Ethylmethylthiambutene
           22.      Etonitazene
           23.      Etoxeridine
           24.      Furethidine
           25.      Hydroxypethidine
           26.      Ketobemidone
           27.      Levomoramide
           28.      Levophenacylmorphan
           29.      Morpheridine
           30.      Noracymethadol
           31.      Norlevorphanol
           32.      Normethadone
           33.      Norpipanone
           34.      Phenadoxone
           35.      Phenampromide
           36.      Phenomorphan
           37.      Phenoperidine
           38.      Piritramide
           39.      Proheptazine
           40.      Properidine
           41.      Racemoramide
           42.      Trimeperidine
           43.      Propiram
           44.      Difenoxin
           45.      Alfentanyl
           46.      Tilidine
           47.      Alphamethylfentanyl (N- [1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-propanilido) piperidine).
     (cC)      Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
           1.      Acetorphine
           2.      Acetyldihydrocodeine
           3.      Benzylmorphine
           4.      Codeine methylbromide
           5.      Codeine-N-Oxide
           6.      Cyprenorphine
           7.      Desomorphine
           8.      Dihydromorphine
           9.      Etorphine
           10.      Heroin
           11.      Hydromorphinol
           12.      Methyldesorphine
           13.      Methylhydromorphine
           14.      Morphine methylbromide
           15.      Morphine methylsulfonate
           16.      Morphine-N-Oxide
           17.      Myrophine
           18.      Nicocodeine
           19.      Nicomorphine
           20.      Normorphine
           21.      Pholcodine
           22.      Thebacon
           23.      Drotebanol
     (dD)      Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
           1.      3,4-methylenedioxy amphetamine
           2.      5-methoxy-3,4-methylenedioxy amphetamine
           3.      3,4-methylenedioxymethamphetamine (MDMA)
           4.       3,4,5-trimethoxy amphetamine
           5.      Bufotenine
           6.      Diethyltryptamine (DET)
           7.      Dimethyltryptamine (DMT)
           8.      4-methyl-2,5-dimethoxyamphetamine (STP)
           9.      Ibogaine
           10.      Lysergic acid diethylamide (LSD)
           11.      Marijuana
           12.      Mescaline
           13.      Peyote
           14.      N-ethyl-3-piperidyl benzilate
           15.      N-methyl-3-piperidyl benzilate
           16.      Psilocybin
           17.      Psilocyn
           18.      Tetrahydrocannabinol (THC)
           19.      2,5-dimethoxyamphetamine
           20.      4-bromo-2,5-dimethoxyamphetamine
           21.      4-Methoxyamphetamine
           22.      Thiophene analog of phencyclidine
           23.      Parahexyl
           24.      Synthetic cannabinoids. - Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:
           a.      Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.
           b.      Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
           c.      Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176.
           d.      Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
           e.      Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.
           f.      Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.
g. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.
           h.      2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone. (WIN 55,212-2).
           i.      9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) - 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370. (HU-210, HU-211).
           j.      Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.
     (eE)      Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers if possible within the specific chemical designation:
           (1)      Mecloqualone;
           (2)      Methaqualone; or
           (3)      Gamma Hydroxybutyric Acid.
     (fF)      Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
           (1)      Fenethylline.;
           (2)      N-ethylamphetamine;
           (3)      Cathinone; or
           (4)      Substituted Cathinones.
Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:
           (a)      by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
           (b)      by substitution at the 3-position with an alkyl substituent;
           (c)      by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or
           (d)      by inclusion of the nitrogen atom in a cyclic structure.
Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone."

SECTION      3.      If any section, subsection, paragraph, subparagraph, sentence, clause, phrase, or word of this act is for any reason held to be unconstitutional or invalid, such holding shall not affect the constitutionality or validity of the remaining portions of this act, the General Assembly hereby declaring that it would have passed this act, and each and every section, subsection, paragraph, subparagraph, sentence, clause, phrase, and word thereof, irrespective of the fact that any one or more other sections, subsections, paragraphs, subparagraphs, sentences, clauses, phrases, or words hereof may be declared to be unconstitutional, invalid, or otherwise ineffective.

SECTION      4.      This act takes effect upon approval by the Governor. /

Renumber sections to conform.
Amend title to conform.